Cargando…

Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia

In acute promyelocytic leukemia (APL) patients, retinoic acid (RA) triggers differentiation while arsenic trioxide (arsenic) induces both a partial differentiation and apoptosis. Although their mechanisms of action are believed to be distinct, these two drugs both induce the catabolism of the oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lallemand-Breitenbach, Valérie, Guillemin, Marie-Claude, Janin, Anne, Daniel, Marie-Thérèse, Degos, Laurent, Kogan, Scott C., Michael Bishop, J., de Thé, Hugues
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1999
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193002/ https://www.ncbi.nlm.nih.gov/pubmed/10190895

Ejemplares similares

In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia
por: Guillemin, Marie-Claude, et al.
Publicado: (2002)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
por: Kogan, Scott C., et al.
Publicado: (2001)

Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection
por: Ribet, David, et al.
Publicado: (2017)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as(2)O(3)-Induced Pml or Pml/Retinoic Acid Receptor α Degradation
por: Lallemand-Breitenbach, Valérie, et al.
Publicado: (2001)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017)

JAK2(V617F) myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
por: Dagher, Tracy, et al.
Publicado: (2020)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018)

All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis
por: Colvin, Teresa A., et al.
Publicado: (2018)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
Publicado: (2017)

Arsenic and all-trans retinoic acid for acute promyelocytic leukemia: yes, it really is as good as it seems
por: Levis, Mark
Publicado: (2021)

Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
por: Kulkarni, Uday P., et al.
Publicado: (2022)

All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
por: Nguyen, Chi H., et al.
Publicado: (2020)

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide
por: Habibi, Maryam, et al.
Publicado: (2021)

Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy
por: Rosati, Giorgio, et al.
Publicado: (2023)

Sumoylation in Physiology, Pathology and Therapy
por: Sahin, Umut, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia
por: Liu, Xiao, et al.
Publicado: (2023)

pH homeostasis in promyelocytic leukemic HL60 cells
Publicado: (1988)

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis
por: Ma, Yafang, et al.
Publicado: (2016)

Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective
por: Kruse, Morgan, et al.
Publicado: (2015)

Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide
por: Newman, A.R., et al.
Publicado: (2018)

All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells
por: Liu, XiangZhen, et al.
Publicado: (2017)

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
por: Zheng, Huyong, et al.
Publicado: (2021)

A practical strategy to subcutaneous administered in-situ gelling co-delivery system of arsenic and retinoic acid for the treatment of acute promyelocytic leukemia
por: Liu, Xiao, et al.
Publicado: (2021)

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
por: Du, Rong, et al.
Publicado: (2021)

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies
por: LU, JIN, et al.
Publicado: (2014)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
por: Zhang, Li, et al.
Publicado: (2018)

Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia
por: Devadas, Santhosh Kumar, et al.
Publicado: (2020)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein
por: Tian, Yuwang, et al.
Publicado: (2014)

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
por: Shen, Yang, et al.
Publicado: (2015)

Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All-Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for High-Risk Acute Promyelocytic Leukemia
por: Danthala, Madhav, et al.
Publicado: (2020)

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)
por: Wang, Huai-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekedb3nvsisam2usjccgartteq